ING Group, N.V. News Headlines

IND 
$25.05
*  
0.23
  negative  
0.91%
Get IND Alerts
*Delayed - data as of Jun. 19, 2013 
Exchange: NYSE
Industry: Finance
Community Rating:
View:    IND After Hours
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

 Save stocks for next time
 | Sponsored
Viewing
Filtered By
Ordered By

FDA Accepts Omeros' IND for OMS824 - Analyst Blog
5/28/2013 7:25:51 PM - Zacks.com

Market Trends Offer Opportunities for FPMI - Analyst Blog
5/20/2013 1:01:01 PM - Zacks.com

Wider-than-Expected Loss at Endocyte - Analyst Blog
5/6/2013 2:18:01 PM - Zacks.com

Loss Widens at Momenta - Analyst Blog
5/2/2013 9:57:19 AM - Zacks.com

AZN/BIND Therapeutics Ink Deal - Analyst Blog
4/23/2013 7:11:20 PM - Zacks.com

ImmunoGen to Focus on Pipeline - Analyst Blog
4/15/2013 7:05:01 PM - Zacks.com

ADC Data from Seattle Genetics - Analyst Blog
4/10/2013 6:08:01 PM - Zacks.com

Idenix Reports In-Line 4Q Loss - Analyst Blog
3/1/2013 11:08:01 AM - Zacks.com

Loss at MNTA Narrower than Expected - Analyst Blog
2/19/2013 5:29:01 PM - Zacks.com

Pipeline Setback for Idenix - Analyst Blog
2/7/2013 6:10:01 PM - Zacks.com

Pipeline Progress at Endocyte - Analyst Blog
1/31/2013 7:30:01 PM - Zacks.com

Wider Loss at ImmunoGen - Analyst Blog
1/28/2013 10:16:01 AM - Zacks.com

Infinity Provides Pipeline Update - Analyst Blog
1/11/2013 1:20:01 PM - Zacks.com

ING Group, N.V. (IND) Ex-Dividend Date Scheduled for November 28, 2012
11/26/2012 10:00:03 AM - NASDAQ.com News

Loss at Elan Wider than Expected - Analyst Blog
10/25/2012 12:20:01 PM - Zacks.com

IND Submission by Synergy Pharma - Analyst Blog
9/17/2012 5:34:01 PM - Zacks.com

AstraZeneca and WuXi Join Forces - Analyst Blog
9/11/2012 5:35:36 PM - Zacks.com

NVLT - Development of CLR1502 (GLOW2) Further Expands Pipeline - Analyst Blog
9/10/2012 11:09:01 AM - Zacks.com

Idenix's Candidate on Clinical Hold - Analyst Blog
8/30/2012 6:25:01 PM - Zacks.com

Alnylam/Isis's Regulus to Go Public - Analyst Blog
8/22/2012 7:18:01 PM - Zacks.com

Elan to Split into Two Companies - Analyst Blog
8/14/2012 10:23:13 AM - Zacks.com

Bad News for ViroPharma - Analyst Blog
8/3/2012 6:14:01 PM - Zacks.com

Positive Data on Alnylam Candidate - Analyst Blog
7/23/2012 5:09:37 PM - Zacks.com

Mid-Day Update: Markets Rise on Corporate Earnings, Bargain Hunting
7/19/2012 12:13:00 PM - MT Newswires

Cubist Initiates Patient Enrolment - Analyst Blog
7/13/2012 3:47:11 PM - Zacks.com